Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - bropair
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mpc86344d735226a69a1900045e5d0cddb
identifier: http://ema.europa.eu/identifier
/EU/1/21/1534/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: BroPair Spiromax 12.75 micrograms/100 micrograms inhalation powder
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-c86344d735226a69a1900045e5d0cddb
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/21/1534/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - bropair
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
BroPair Spiromax contains 2 active substances: salmeterol and fluticasone propionate:
BroPair Spiromax is used to treat asthma in adults and adolescents aged 12 years and older.
BroPair Spiromax helps to prevent breathlessness and wheeziness coming on. You should not use it to relieve an asthma attack. If you have an asthma attack, use a fast-acting reliever (rescue) inhaler, such as salbutamol. You should always have your fast-acting rescue inhaler with you.
Do not use BroPair Spiromax
Warnings and precautions
Talk to your doctor, pharmacist or nurse before using BroPair Spiromax if you have:
Contact your doctor if you experience blurred vision or other visual disturbances.
Children and adolescents Do not give this medicine to children or adolescents under the age of 12 years because it has not been studied in this age group.
Other medicines and BroPair Spiromax Tell your doctor, nurse or pharmacist if you are taking or, have recently taken or might use any other medicines. BroPair Spiromax may not be suitable for use with some other medicines.
Tell your doctor if you are taking the following medicines, before starting to use BroPair Spiromax:
Some medicines may increase the effects of BroPair Spiromax and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).
Pregnancy and breast-feeding
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor, nurse or pharmacist for advice before taking this medicine.
It is not known if this medicine can pass into breast milk. If you are breast-feeding, check with your doctor, nurse or pharmacist before taking this medicine.
Driving and using machines BroPair Spiromax is not likely to affect your ability to drive or use machines.
BroPair Spiromax contains lactose Each dose of this medicine contains approximately 5.4 milligrams of lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one inhalation twice a day.
Your doctor or nurse will help you to manage your asthma. The doctor or nurse will change your inhaler medicine if you need a different dose to control your asthma properly. However, do not change the number of inhalations your doctor or nurse has prescribed without talking to your doctor or nurse first.
If your asthma or breathing gets worse tell your doctor straight away. If you feel more wheezy, your chest feels tight more often, or you need to use more of your fast-acting reliever medicine, your asthma may be getting worse and you could become seriously ill. Continue to use BroPair Spiromax but do not increase the number of inhalations you take. See your doctor at once as you may need additional treatment.
Instructions for use
Training Your doctor, nurse, or pharmacist should train you on how to use your inhaler, including how to inhale a dose effectively. This training is important to ensure you receive the dose you require. If you have not received this training please ask your doctor, nurse or pharmacist to show you how to use your inhaler properly before you use it for the first time.
Your doctor, nurse, or pharmacist should also check from time to time that you are using the Spiromax device properly and as prescribed. If you are not using BroPair Spiromax properly or you are not breathing it in forcefully enough, you may not be getting enough medicine into your lungs. This means that the medicine will not help your asthma as well as it should.
Preparing your BroPair Spiromax
Before using your BroPair Spiromax for the first time, you need to prepare it for use as follows: Check the dose indicator to see that there are 60 inhalations in the inhaler. Write the date you opened the foil pouch on the label on the inhaler. You do not need to shake your inhaler before you use it.
How to take an inhalation
Hold your inhaler with the semi-transparent yellow mouthpiece cover at the bottom.
Open the mouthpiece cover by folding it down until you hear a loud click. This will measure out one dose of your medicine. Your inhaler is now ready for use.
Breathe out gently (as far as is comfortable). Do not breathe out through your inhaler.
Put the mouthpiece in your mouth and close your lips tightly around it. Take care not to block the air vents.
Breathe in through your mouth as deeply and as hard as you can.
Note that it is important that you breathe in forcefully.
Remove your inhaler from your mouth. You may notice a taste when you take your inhalation.
Hold your breath for 10 seconds or as long as you comfortably can.
Then breathe out gently (do not breathe out through the inhaler).
Close the mouthpiece cover.
Cleaning your Spiromax Keep your inhaler dry and clean. If necessary you may wipe the mouthpiece of your inhaler after use with a dry cloth or tissue.
When to start using a new BroPair Spiromax
The dose indicator on the rear of the device tells you how many doses (inhalations) are left in your inhaler, starting at 60 when it is full and ending with 0 (zero) when it is empty.
The dose indicator shows the number of inhalations remaining as even numbers. The spaces between the even numbers represent the odd number of remaining inhalations.
When 20 or fewer are left, the numbers are shown in red on a white background. When the red numbers appear in the window, you should see your doctor or nurse to get a new inhaler.
Note:
If you use more BroPair Spiromax than you should It is important that you take the dose that your doctor or nurse has prescribed. You should not exceed the prescribed dose without medical advice. If you accidentally take more doses than recommended, talk to your nurse, doctor or pharmacist. You may notice your heart beating faster than usual and that you feel shaky. You may also have dizziness, a headache, muscle weakness and aching joints.
If you have repeatedly used too many doses of BroPair Spiromax for a long time, you should talk to your doctor or pharmacist for advice. This is because using too much BroPair Spiromax can reduce the amount of steroid hormones produced by your adrenal glands.
If you forget to use BroPair Spiromax If you forget to take a dose, take it as soon as you remember. However do not take a double dose to make up for a forgotten dose. If it is nearly time for your next dose just take your next dose at the usual time.
If you stop using BroPair Spiromax It is very important that you take your BroPair Spiromax every day as advised. Keep taking it until your doctor tells you to stop. Do not stop or suddenly reduce your dose of BroPair Spiromax. This could make your breathing worse.
In addition, if you suddenly stop taking BroPair Spiromax or reduce your dose of BroPair Spiromax this may (very rarely) cause problems due to your adrenal glands producing reduced amounts of steroid hormone (adrenal insufficiency) which sometimes causes side effects.
These side effects may include any of the following:
When your body is under stress such as from fever, accident or injury, infection, or surgery, adrenal insufficiency can get worse and you may also have the side effects listed above.
If you get any side effects, talk to your doctor or pharmacist. To prevent these symptoms, your doctor may prescribe extra corticosteroids in tablet form (such as prednisolone).
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. To reduce the chance of side effects your doctor will prescribe the lowest dose of this combination of drugs to control your asthma.
Allergic reactions: you may notice your breathing suddenly gets worse immediately after using BroPair Spiromax. You may be very wheezy and cough or be short of breath. You may also notice itching, a rash (hives) and swelling (usually of the face, lips, tongue or throat), or you may suddenly feel that your heart is beating very fast or you feel faint and light headed (which may lead to collapse or loss of consciousness). If you get any of these effects or if they happen suddenly after using BroPair Spiromax, stop using BroPair Spiromax and tell your doctor straight away. Allergic reactions to BroPair Spiromax are uncommon (they may affect up to 1 in 100 people).
Other side effects are listed below:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Slowing of growth in children and adolescents
Glaucoma (damage to the nerve in the eye)
Rounded (moon shaped) face (Cushing s syndrome).
Your doctor will check you regularly for any of these side effects and make sure you are taking the lowest dose of this combination of drugs to control your asthma.
Frequency not known, but may also occur:
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the label of your inhaler after EXP. The expiry date refers to the last day of that month.
Do not store above 25 oC. Keep the mouthpiece cover closed after removing the foil wrapping. Use within 2 months of removing from the foil wrapping. Use the label on the inhaler to write down the date you open the foil pouch.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What BroPair Spiromax contains
What BroPair Spiromax looks like and contents of the pack Each BroPair Spiromax inhaler contains inhalation powder for 60 inhalations and has a white body with a semi-transparent yellow mouthpiece cover.
BroPair Spiromax is available in packs containing 1 inhaler and in multipacks containing 3 cartons, each containing 1 inhaler. Not all pack sizes may be marketed in your country.
Marketing Authorisation Holder
Teva B.V. Swensweg 5,
2031 GA Haarlem,
The Netherlands
Manufacturer Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland Unit 14/15, 27/35 & 301, IDA Industrial Park, Cork Road, Waterford, Ireland
Teva Operations Poland Sp. z o.o.
Mogilska 80 Str. 31-546 Krak w, Poland
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Belgi /Belgique/Belgien Teva Pharma Belgium N.V./S.A./AG
Tel/T l: +32 3 820 73 Lietuva UAB Teva Baltics Tel: +370 5 266 02
Te : +359 2 489 95 Luxembourg/Luxemburg Teva Pharma Belgium N.V./S.A./AG
Tel/T l: +32 3 820 73 esk republika Teva Pharmaceuticals CR, s.r.o.
Tel: +420 251 007 Magyarorsz g Teva Gy gyszergy r Zrt
Tel.: +36 1 288 64 Danmark Teva Denmark A/S
Tlf: +45 44 98 55 Malta Teva Pharmaceuticals Ireland L-Irlanda Tel: +44 207 540 7Deutschland Teva GmbH Tel: +49 731 402 Nederland Teva Nederland B.V. Tel: +31 800 0228 Eesti UAB Teva Baltics Eesti filiaal Tel: +372 661 0Norge Teva Norway AS
Tlf: +47 6677 55
Specifar A.B.E.E. : +30 211 880 5 sterreich ratiopharm Arzneimittel Vertriebs GmbH Tel: +43 1 97007 0
Espa a Laboratorios BIAL, S.A. T l: +34 915624Polska Teva Pharmaceuticals Polska Sp. z o.o. Tel.: +48 22 345 93 France Teva Sant
T l: +33 1 55 91 7Portugal
Teva Pharma - Produtos Farmac uticos Lda Tel: +351 21 476 75 Hrvatska Pliva Hrvatska d.o.o Tel: + 385 1 37 20 Rom nia Teva Pharmaceuticals S.R.L Tel: +4021 230 6Ireland Teva Pharmaceuticals Ireland Tel: +34 915624Slovenija Pliva Ljubljana d.o.o. Tel: +386 1 58 90 sland Teva Pharma Iceland ehf Simi: +354 550 3Slovensk republika Teva Pharmaceuticals Slovakia s.r.o. Tel: +421 2 5726 7Italia Teva Italia S.r.l. Tel: +39 028 917 Suomi/Finland Teva Finland Oy Puh/Tel: +358 20 180 5
Specifar A.B.E.E.
: +30 211 880 5Sverige Teva Sweden AB Tel: +46 42 12 11 Latvija Teva Baltics fili le Latvij
Tel: +371 673 23 United Kingdom (Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 207 540 7This leaflet was last revised in.
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-c86344d735226a69a1900045e5d0cddb
Resource Composition:
Generated Narrative: Composition composition-en-c86344d735226a69a1900045e5d0cddb
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/21/1534/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - bropair
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mpc86344d735226a69a1900045e5d0cddb
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mpc86344d735226a69a1900045e5d0cddb
identifier:
http://ema.europa.eu/identifier
/EU/1/21/1534/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: BroPair Spiromax 12.75 micrograms/100 micrograms inhalation powder
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en